Harvard Bioscience (HBIO) Treasury Shares (2010 - 2026)

Harvard Bioscience (HBIO) has 12 years of Treasury Shares data on file, last reported at $10.7 million in Q1 2021.

• Quarterly Treasury Shares changed 0.0% year-over-year to $10.7 million in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $10.7 million (changed 0.0% YoY) and the FY2020 annual result came in at $10.7 million, changed 0.0% from the prior year.
• Treasury Shares steadied at $10.7 million in Q1 2021 per HBIO's latest filing, from $10.7 million in the prior quarter.
• Across five years, Treasury Shares topped out at $2.0 million in Q3 2023 and bottomed at $50000.0 in Q4 2025.
• The 5-year median for Treasury Shares is $764539.0 (2022), against an average of $775988.6.
• Peak annual rise in Treasury Shares reached 0.0% in 2017, while the deepest fall reached 0.0% in 2017.
• Tracing HBIO's Treasury Shares over 5 years: stood at $10.7 million in 2017, then changed by 0.0% to $10.7 million in 2018, then changed by 0.0% to $10.7 million in 2019, then changed by 0.0% to $10.7 million in 2020, then changed by 0.0% to $10.7 million in 2021.
• Per Business Quant, the three latest HBIO Treasury Shares figures stand at $10.7 million (Q1 2021), $10.7 million (Q4 2020), and $10.7 million (Q3 2020).

Peer Comparison